Drug intelligence / Profile preview

Lactobacillus animalis

Development stage: Unknown
Lead developer: Chr. Hansen
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobacillus animalis, recently reclassified as Ligilactobacillus animalis, is a species of gram-positive, homofermentative lactic acid bacteria. It is naturally found in the gastrointestinal tracts of animals and humans. As a probiotic, L. animalis is recognized for its role in promoting gut health by enhancing the growth of beneficial bacteria, inhibiting pathogenic microorganisms, and improving digestion and nutrient absorption. Its mechanisms of action include the production of lactic acid, which helps create an acidic gut environment unfavorable to pathogens, and contributing to the production of short-chain fatty acids (SCFAs) that support the integrity of the gut lining and reduce inflammation. It is used in both human dietary supplements and veterinary applications, often in combination with other probiotic strains, to support digestive health and modulate the immune system.

Other names: Ligilactobacillus animalis

Beyond the preview

Go deeper on Lactobacillus animalis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus animalis.

Explore the full profile